Enfermedades respiratorias

enfermedades

Campaña

PULMÓN SANO, FUTURO SANO, ES EL MOMENTO DE CUIDAR TU SALUD RESPIRATORIA

Accede

Conoce más sobre GSK

Referencias

  1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Internet] 2025. [Último acceso: marzo 2025]. Disponible en https://goldcopd.org/2025-gold-report/
  2. World Health Organization. Asthma. WHO website. Disponible en: https://www.who.int/news-room/fact-sheets/detail/asthma [Último acceso: marzo 2025] 
  3. AlBloushi S, Al-Ahmad M. Exploring the immunopathology of type 2 inflammatory airway diseases. Front Immunol. 2024 Apr 12;15:1285598. doi: 10.3389/fimmu.2024.1285598. PMID: 38680486; PMCID:pmc11045947" to "Schleimer RP. Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol. 2017 Jan 24;12:331-357
  4. Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019 Dec;74(12):2312-2319. doi: 10.1111/all.13875. Epub 2019 Jul 15. PMID: 31090937; PMCID: PMC6972984.
  5. Booker R. Effective communication with the patient. Eur Respir Rev [Internet]. 2005;14(96):93–6. Disponible en: http://err.ersjournals.com/content/14/96/93.abstract
  6. American Lung Association. COPD: What patients and caregivers should know [Internet]. Lung.org. [Último acceso: marzo 2025]. Disponible en: https://www.lung.org/blog/copd-what-you-should-know

UA March 2025: NP-ES-ASU-WCNT-220005(v2)